Advanced search
Publication Cover
Pharmaceutical Biology Volume 54, 2016 - Issue 11
Submit an article Journal homepage
3,050
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Synergistic anticancer effects of andrographolide and paclitaxel against A549 NSCLC cells

Huihui YuanShanghai Key Laboratory of Functional Materials Chemistry, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai, China; Correspondence[email protected]
,
Bo SunShanghai Key Laboratory of Functional Materials Chemistry, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai, China;
,
Feng GaoDepartment of Pharmaceutics, School of Pharmacy, East China University of Science and Technology, Shanghai, China;
&
Minbo LanShanghai Key Laboratory of Functional Materials Chemistry, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai, China; ;State Key Laboratory of Bioreactor Engineering, School of Biotechnology, East China University of Science and Technology, Shanghai, ChinaCorrespondence[email protected]
Pages 2629-2635 | Received 25 Jun 2015, Accepted 05 Apr 2016, Published online: 09 May 2016

References

  • Alexandre J, Batteux F, Nicco C, Chéreau C, Laurent A, Guillevin L, Weill B, Goldwasser F. 2006. Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer. 119:41–48.
  • Almohaimeed B, Donev AN. 2014. Experimental designs for drug combination studies. Comput Stat Data Anal. 71:1077–1087.
  • Boztas AO, Karakuzu O, Galante G, Ugur Z, Kocabas F, Altuntas CZ, Yazaydin AO. 2013. Synergistic interaction of paclitaxel and curcumin with cyclodextrin polymer complexation in human cancer cells. Mol Pharm. 10:2676–2683.
  • Chairuangkitti P, Lawanprasert S, Roytrakul S, Aueviriyavit S, Phummiratch D, Kulthong K, Chanvorachote P, Maniratanachote R. 2013. Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways. Toxicol In Vitro. 27:330–338.
  • Chandel NS, Tuveson DA. 2014. The promise and perils of antioxidants for cancer patients. N Engl J Med. 371:177–178.
  • Chou TC. 2010. Drug combination studies and their synergy quantification using the Chou–Talalay method. Cancer Res. 70:440–446.
  • Crosasso P, Ceruti M, Brusa P, Arpicco S, Dosio F, Cattel L. 2000. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release. 63:19–30.
  • Finkel T. 2011. Signal transduction by reactive oxygen species. J Cell Biol. 194:7–15.
  • Fitzpatrick F, Wheeler R. 2003. The immunopharmacology of paclitaxel (Taxol), docetaxel (Taxotere), and related agents. Int Immunopharmacol. 3:1699–1714.
  • Hou ZH, Zhao WC, Zhang Q, Zheng W. 2015. Effect of paclitaxel-loaded nanoparticles on the viability of human hepatocellular carcinoma HepG2 cells. Asian Pac J Cancer Prev. 16:1725–1728.
  • In LL, Azmi MN, Ibrahim H, Awang K, Nagoor NH. 2011. 1′S-1′-Acetoxyeugenol acetate: a novel phenylpropanoid from Alpinia conchigera enhances the apoptotic effects of paclitaxel in MCF-7 cells through NF-κB inactivation. Anticancer Drugs. 22:424–434.
  • Jakel A, Plested M, Dharamshi K, Modha R, Bridge S, Johns A. 2013. A systematic review of economic evaluations in second and later lines of therapy for the treatment of non-small cell lung cancer. Appl Health Econ Health Policy. 11:27–43.
  • Lee YC, Lin HH, Hsu CH, Wang CJ, Chiang TA, Chen JH. 2010. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway. Eur J Pharmacol. 632:23–32.
  • Lin HH, Tsai CW, Chou FP, Wang CJ, Hsuan SW, Wang CK, Chen JH. 2011. Andrographolide down-regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells. Toxicol Appl Pharmacol. 250:336–345.
  • Liu K, Cang S, Ma Y, Chiao JW. 2013. Synergistic effect of paclitaxel and epigenetic agent phenethyl isothiocyanate on growth inhibition, cell cycle arrest and apoptosis in breast cancer cells. Cancer Cell Int. 13:10.
  • Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A, et al. 1991. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst. 83:757–766.
  • Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108.
  • Parveen R, Ahmad FJ, Iqbal Z, Samim M, Ahmad S. 2014. Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies. Drug Dev Ind Pharm. 49:1206–1212.
  • Rajagopal S, Kumar RA, Deevi DS, Satyanarayana C, Rajagopalan R. 2003. Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J Exp Ther Oncol. 3:147–158.
  • Razi SS, Rehmani S, Li X, Park K, Schwartz GS, Latif MJ, Bhora FY. 2014. Antitumor activity of paclitaxel is significantly enhanced by a novel proapoptotic agent in non-small cell lung cancer. J Surg Res. 194:622–630.
  • Wang L, Liu X, Wu Y, Wu W, Wu Y. 2012. Involvement of ROS in the inhibitory effect of thermotherapy combined with chemotherapy on A549 human lung adenocarcinoma cell growth through the Akt pathway. Oncol Rep. 28:1369–1375.
  • Yang S, Evens AM, Prachand S, Singh AT, Bhalla S, David K, Gordon LI. 2010. Mitochondrial-mediated apoptosis in lymphoma cells by the diterpenoid lactone andrographolide, the active component of Andrographis paniculata. Clin Cancer Res. 16:4755–4768.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.